deaths (OS)

Extensive stage SCLC (Es-SCLC) - 1st Line (L1) Extensive stage SCLC (Es-SCLC) Extensive stage SCLC (Es-SCLC) - 1st Line (L1)

versus placebo plus SoC
pembrolizumab plus SoC vs. placebo plus SoC 1 -943 [-1690; -196] /10000
169/228 vs. 188/225